Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588277 | SCV000695690 | uncertain significance | not provided | 2017-04-28 | criteria provided, single submitter | clinical testing | Variant summary: The GALT c.377+7A>G variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a damaging outcome for this variant. 3/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 1/121326 control chromosomes at a frequency of 0.0000082, which does not exceed the estimated maximal expected allele frequency of a pathogenic GALT variant (0.0028868). The variant of interest has been reported in 1 newborn with elevated galactose level, however his repeated test results were wnl. The c.377+7A>G variant has not been cited by any reputable databases/clinical diagnostic laboratories. Due to the absence of clinical information and lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available. |
Invitae | RCV002065130 | SCV002450673 | likely benign | Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase | 2023-11-10 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001276264 | SCV001462313 | uncertain significance | Galactosemia | 2020-09-16 | no assertion criteria provided | clinical testing |